| 000 | 01351 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516153908.0 | ||
| 264 | 0 | _c20130923 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1432-072X | ||
| 024 | 7 |
_a10.1007/s00203-013-0905-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNaghmouchi, Karim | |
| 245 | 0 | 0 |
_aRequired characteristics of Paenibacillus polymyxa JB-0501 as potential probiotic. _h[electronic resource] |
| 260 |
_bArchives of microbiology _cAug 2013 |
||
| 300 |
_a537-43 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAntibiosis |
| 650 | 0 | 4 | _aBacterial Adhesion |
| 650 | 0 | 4 |
_aBile Acids and Salts _xpharmacology |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 | _aCarbohydrate Metabolism |
| 650 | 0 | 4 |
_aEscherichia coli _xgrowth & development |
| 650 | 0 | 4 | _aGastric Acid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aMuramidase _xpharmacology |
| 650 | 0 | 4 |
_aPaenibacillus _xgrowth & development |
| 650 | 0 | 4 | _aProbiotics |
| 700 | 1 | _aBaah, John | |
| 700 | 1 | _aCudennec, Benoit | |
| 700 | 1 | _aDrider, Djamel | |
| 773 | 0 |
_tArchives of microbiology _gvol. 195 _gno. 8 _gp. 537-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00203-013-0905-7 _zAvailable from publisher's website |
| 999 |
_c22826393 _d22826393 |
||